Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | HPRT1 | P00492 | 4/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.48 |
| ▸ | FYN | P06241 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | AHR | P35869 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25812022 | 0.98 | HPRT1 (0.64) | ALDH1A1HSD17B10CYP1B1HIF1AHPRT1 | |
| SCHEMBL18828382 | 0.88 | ALDH1A1 (0.64) | ALDH1A1HSD17B10CYP1B1HIF1AHPRT1 | |
| SCHEMBL12809407 | 0.87 | ALDH1A1 (0.39) | ALDH1A1HSD17B10CYP1B1HIF1AHPRT1 | |
| SCHEMBL22705421 | 0.85 | HPRT1 (0.41) | ALDH1A1HSD17B10CYP1B1HIF1AHPRT1 | |
| SCHEMBL27259534 | 0.83 | ALDH1A1 (0.52) | ALDH1A1HSD17B10CYP1B1HIF1AHPRT1 | |
| SCHEMBL10285373 | 0.80 | ALDH1A1 (0.48) | ALDH1A1HSD17B10CYP1B1HIF1AHPRT1 | |
| SCHEMBL319839 | 0.79 | CYP2A6 (0.48) | ALDH1A1HSD17B10HIF1ACYP2A6TDP1 | |
| SCHEMBL25056778 | 0.77 | CYP2A6 (0.42) | ALDH1A1HSD17B10CYP1B1HIF1AHPRT1 | |
| SCHEMBL4852455 | 0.77 | ALDH1A1 (0.89) | ALDH1A1HSD17B10CYP1B1HIF1AHPRT1 | |
| SCHEMBL11959837 | 0.77 | ALDH1A1 (0.50) | ALDH1A1HSD17B10CYP1B1HIF1ACYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107849001-A | Compound, material for organic electroluminescent element, and electronic device | 出光兴产株式会社 | 2018-03-27 | — | — | CN | disclosed |
| EP-1888539-B1 | HYDROXYPHENYLTRIAZINES WITH AN AROMATIC CARBOCYCLIC FUSED RING SYSTEM | BASF SE (DE) | 2013-09-18 | — | — | EP | disclosed |
| US-8134035-B2 | Preparation of asymmetric anthracene derivatives and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2012-03-13 | — | — | US | disclosed |
| US-20110065924-A1 | PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2011-03-17 | — | — | US | disclosed |
| WO-2010114256-A2 | NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | DOW ADVANCED DISPLAY MATERIALS,LTD. (KR) | 2010-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065924-A1 | PREPARATION OF ASYMMETRIC ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | AKR7A2, ACMSD, ALKBH3 | ALDH1A1 1554/4885HSD17B10 391/4885CYP1B1 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.